tiprankstipranks
AbbVie says Humira downdraft ‘within what was assumed’
PremiumThe FlyAbbVie says Humira downdraft ‘within what was assumed’
12d ago
AbbVie sees FY24 revenue approximately $55B, consensus $54.6B
PremiumThe Fly
AbbVie sees FY24 revenue approximately $55B, consensus $54.6B
12d ago
AbbVie sees Q2 adjusted EPS $3.05-$3.09, consensus $2.81
PremiumThe Fly
AbbVie sees Q2 adjusted EPS $3.05-$3.09, consensus $2.81
12d ago
AbbVie reports Q1 adjusted EPS $2.31, consensus $2.23
PremiumThe FlyAbbVie reports Q1 adjusted EPS $2.31, consensus $2.23
12d ago
Options Volatility and Implied Earnings Moves Today, April 26, 2024
PremiumMarket News
Options Volatility and Implied Earnings Moves Today, April 26, 2024
12d ago
Notable companies reporting before tomorrow’s open
PremiumThe Fly
Notable companies reporting before tomorrow’s open
12d ago
AbbVie reports ‘positive’ results from Phase 3 SELECT-GCA study of upadacitinib
PremiumThe FlyAbbVie reports ‘positive’ results from Phase 3 SELECT-GCA study of upadacitinib
20d ago
Fake Botox Fight Sends AbbVie (NASDAQ:ABBV) Up Fractionally
PremiumMarket News
Fake Botox Fight Sends AbbVie (NASDAQ:ABBV) Up Fractionally
22d ago
AbbVie Stock (NYSE:ABBV): Humira Leads Market with 96% Share
PremiumMarket News
AbbVie Stock (NYSE:ABBV): Humira Leads Market with 96% Share
23d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100